Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beyond Meat Inc | Ethan Brown | President, Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,874,772 | 25,918,606 (42%) | 32% | 0 | Common Stock | |
| Beyond Meat Inc | Lubi Kutua | CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 5,440,719 | 6,419,721 (10%) | 8% | 0 | Common Stock | |
| Beyond Meat Inc | Teri L. Witteman | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 3,726,520 | 4,380,743 (7%) | 6% | 0 | Common Stock | |
| Snap Inc (Class A) | Zachary M. Briers | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 2,988,793 | 2,988,793 (0%) | 0% | 0 | Class A Common Stock | |
| AST SpaceMobile Inc (Class A) | Abel Antonio Avellan | Director, Chief Executive Officer, Ten Percent Owner | 19 Nov 2025 | 2,500,000 | 2,500,000 | - | - | Forward contract (obligation to sell) | ||
| Beyond Meat Inc | Dariush Ajami | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 2,484,347 | 3,216,219 (5%) | 4% | 0 | Common Stock | |
| Axis Cap Holdings Ltd | Charles A. Davis | Director | Sale of securities on an exchange or to another person at price $ 98.90 per share. | 19 Nov 2025 | 2,404,133 | 0 (0%) | 2% | 98.9 | 237,768,754 | Common Shares |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 19 Nov 2025 | 2,300,000 | 26,245,633 (42%) | 3% | 0 | Class C Common Stock | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | 19 Nov 2025 | 2,300,000 | 26,245,633 | - | - | Common Units | ||
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | 19 Nov 2025 | 2,300,000 | 2,300,000 (3%) | 3% | 0 | Class A Common Stock | ||
| Nuvve Holding Corp | Gregory Poilasne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 2,000,000 | 2,002,312 | - | - | Employee Stock Option (Right to Buy) | |
| Marwynn Holdings Inc | Yin Yan | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 19 Nov 2025 | 1,777,230 | 0 | - | 0.5 | 906,387 | Common Stock |
| Nuvve Holding Corp | Gregory Poilasne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 1,323,000 | 1,656,474 | - | 0 | Common Stock | |
| Precigen Inc | Randal J. Kirk | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 19 Nov 2025 | 1,086,153 | 7,434,384 (4%) | 0% | 4.5 | 4,855,104 | Common Stock |
| Energy Transfer LP - Unit | Kelcy L. Warren | Director | Purchase of securities on an exchange or from another person at price $ 16.81 per share. | 19 Nov 2025 | 1,000,000 | 105,577,803 (3%) | 0% | 16.8 | 16,810,000 | Common Units |
| Energy Transfer LP - Unit | Kelcy L. Warren | Director | Purchase of securities on an exchange or from another person at price $ 16.95 per share. | 19 Nov 2025 | 1,000,000 | 104,577,803 (3%) | 0% | 17.0 | 16,950,000 | Common Units |
| Butterfly Network Inc (Class A) | Larry M. Robbins | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 19 Nov 2025 | 1,000,000 | 10,955,144 | - | 2.4 | 2,353,900 | Class A Common Stock |
| Butterfly Network Inc (Class A) | Larry M. Robbins | Director | Purchase of securities on an exchange or from another person at price $ 2.37 per share. | 19 Nov 2025 | 1,000,000 | 11,955,144 | - | 2.4 | 2,366,000 | Class A Common Stock |
| Nuvve Holding Corp | David G. Robson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 1,000,000 | 1,000,876 | - | - | Employee Stock Option (Right to Buy) | |
| Paymentus Holdings Inc (Class A) | Robert Palumbo | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 19 Nov 2025 | 1,000,000 | 4,364,707 | - | - | Class B Common Stock | |
| Precigen Inc | Randal J. Kirk | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 19 Nov 2025 | 942,832 | 6,491,552 (3%) | 0% | 4.1 | 3,846,755 | Common Stock |
| Precigen Inc | Randal J. Kirk | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 19 Nov 2025 | 937,308 | 5,554,244 (3%) | 0% | 3.8 | 3,589,890 | Common Stock |
| Nuvve Holding Corp | David G. Robson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 937,125 | 940,566 | - | 0 | Common Stock | |
| Roivant Sciences Ltd | Keith Manchester | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 19 Nov 2025 | 850,000 | 18,497,727 | - | 20.3 | 17,212,500 | Common Shares |
| Roivant Sciences Ltd | Daniel Gold | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 19 Nov 2025 | 850,000 | 18,497,727 | - | 20.3 | 17,212,500 | Common Shares |
| Butterfly Network Inc (Class A) | Larry M. Robbins | Director | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 19 Nov 2025 | 800,000 | 12,755,144 | - | 2.6 | 2,064,160 | Class A Common Stock |
| EZCorp Inc (Class A) | Lachlan P. Given | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 352,786 | 1,128,600 (2%) | 0% | 17.8 | 6,286,647 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Lachlan P. Given | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 352,786 | 871,929 | - | - | Restricted Stock Units | |
| Mitek Systems Inc | Edward H. West | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 344,037 | 1,098,452 | - | - | Performance Restricted Stock Units | |
| Rezolute Inc | Nevan Charles Elam | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 317,000 | 609,119 | - | 0 | Common Shares | |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 71.91 per share. | 19 Nov 2025 | 300,000 | 677,796 | - | 71.9 | 21,573,000 | Common Stock |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 300,000 | 633,916 | - | - | Stock Option (Right to Buy) | |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 19 Nov 2025 | 300,000 | 977,796 | - | 2.4 | 726,000 | Common Stock |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 19 Nov 2025 | 270,578 | 30,779,769 | - | 0.9 | 246,226 | Class A Common Stock |
| TPG Inc (Class A) | Jon Winkelried | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 238,984 | 3,289,908 | - | 0 | Class A Common Stock | |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 19 Nov 2025 | 200,000 | 224,000 | - | 1.9 | 374,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 200,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 7.14 per share. | 19 Nov 2025 | 200,000 | 24,000 | - | 7.1 | 1,427,680 | Class A Common Stock |
| Nuvve Holding Corp | Ted Smith | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 200,000 | 201,710 | - | - | Employee Stock Option (Right to Buy) | |
| TPG Inc (Class A) | Todd B. Sisitsky | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 200,000 | 172,766 | - | 0 | Class A Common Stock | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 19 Nov 2025 | 198,904 | 215,390,952 (32%) | 0% | 1.3 | 261,559 | Common Stock |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 192,056 | 0 (0%) | 1% | - | Common Stock | |
| Rezolute Inc | Nevan Charles Elam | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 186,000 | 186,000 | - | - | Employee Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Keith Manchester | Director | Sale of securities on an exchange or to another person at price $ 20.24 per share. | 19 Nov 2025 | 175,000 | 18,047,727 | - | 20.2 | 3,542,000 | Common Shares |
| Roivant Sciences Ltd | Daniel Gold | Director | Sale of securities on an exchange or to another person at price $ 20.24 per share. | 19 Nov 2025 | 175,000 | 18,047,727 | - | 20.2 | 3,542,000 | Common Shares |
| Mitek Systems Inc | Garrett Gafke | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 172,019 | 532,595 | - | - | Performance Restricted Stock Units | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 19 Nov 2025 | 155,496 | 215,546,448 (32%) | 0% | 1.3 | 205,255 | Common Stock |
| Eventbrite Inc (Class A) | Anand Gandhi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 19 Nov 2025 | 150,454 | 1,233,629 (1%) | 0% | 2.6 | 385,162 | Class A Common Stock |
| Roivant Sciences Ltd | Keith Manchester | Director | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 19 Nov 2025 | 150,000 | 18,347,727 | - | 20.2 | 3,030,000 | Common Shares |
| Roivant Sciences Ltd | Daniel Gold | Director | Sale of securities on an exchange or to another person at price $ 20.20 per share. | 19 Nov 2025 | 150,000 | 18,347,727 | - | 20.2 | 3,030,000 | Common Shares |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 149,006 | 718,362 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 149,006 | 867,368 (1%) | 0% | 0 | Common Stock | |
| EZCorp Inc (Class A) | John Blair Powell | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 145,522 | 291,505 (0%) | 0% | 17.8 | 2,593,202 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | John Blair Powell | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 145,522 | 371,385 | - | - | Restricted Stock Units | |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 128,818 | 0 | - | - | Stock Option (Right to Buy) | |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 44.54 per share. | 19 Nov 2025 | 128,818 | 861,312 (0%) | 0% | 44.5 | 5,738,121 | Common Stock |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.73 per share. | 19 Nov 2025 | 128,818 | 1,035,130 (0%) | 0% | 29.7 | 3,829,759 | Common Stock |
| Sensata Tech Holding PLC | John Mirshekari | Director | Sale of securities on an exchange or to another person at price $ 28.83 per share. | 19 Nov 2025 | 125,939 | 142,371 (0%) | 0% | 28.8 | 3,631,111 | Ordinary Shares, par value EUR 0.01 per share |
| Roivant Sciences Ltd | Keith Manchester | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 19 Nov 2025 | 125,000 | 18,222,727 | - | 20.2 | 2,520,000 | Common Shares |
| Roivant Sciences Ltd | Daniel Gold | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 19 Nov 2025 | 125,000 | 18,222,727 | - | 20.2 | 2,520,000 | Common Shares |
| Mangoceuticals Inc | Alex P. Hamilton | Director | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 19 Nov 2025 | 125,000 | 3,334 | - | 1.2 | 152,875 | Common Stock |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 123,000 | 280,352 | - | 0 | Common Shares | |
| Cabot Corp | Sean D. Keohane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 122,114 | 122,114 | - | - | Employee Stock Option (Right to Buy) | |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 120,966 | 988,334 (1%) | 0% | 0 | Common Stock | |
| Mitek Systems Inc | Edward H. West | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 8.72 per share. | 19 Nov 2025 | 114,679 | 419,608 (1%) | 0% | 8.7 | 1,000,001 | Common Stock |
| EZCorp Inc (Class A) | Lachlan P. Given | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 110,155 | 1,224,715 | - | - | Restricted Stock Units | |
| Sensata Tech Holding PLC | John Mirshekari | Director | Sale of securities on an exchange or to another person at price $ 28.75 per share. | 19 Nov 2025 | 108,438 | 33,933 (0%) | 0% | 28.8 | 3,117,842 | Ordinary Shares, par value EUR 0.01 per share |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 107,000 | 375,900 | - | 0 | Common Shares | |
| Radnet Inc | Howard G. Berger | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.64 per share. | 19 Nov 2025 | 103,969 | 322,420 (0%) | 0% | 18.6 | 1,937,982 | Common Stock |
| Radnet Inc | Howard G. Berger | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 103,969 | 0 | - | - | Stock Option (right to buy) | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 101,010 | 101,010 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Ashland Inc | Guillermo Novo | Director, Chair of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 97,864 | 97,864 | - | - | Stock Appreciation Rights | |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 96,748 | 96,748 | - | - | Employee Stock Option (Right to Buy) | |
| TPG Inc (Class A) | Jeffrey K. Rhodes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 91,492 | 0 | - | 0 | Class A Common Stock | |
| Intercontinental Exchange | Jeffrey C. Sprecher | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.40 per share. | 19 Nov 2025 | 89,361 | 1,801,705 (0%) | 0% | 153.4 | 13,707,799 | Common Stock |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 89,127 | 0 | - | - | Employee Stock Option (right to buy) | |
| EZCorp Inc (Class A) | Timothy K. Jugmans | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 88,195 | 260,773 | - | - | Restricted Stock Units | |
| EZCorp Inc (Class A) | Timothy K. Jugmans | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 88,195 | 238,036 (0%) | 0% | 17.8 | 1,571,635 | Class A Non-Voting Common Stock |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 84,669 | 0 | - | - | Employee Stock Option (right to buy) | |
| Marriott Vacations Worldwide Corp | Christian A. Asmar | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 47.44 per share. | 19 Nov 2025 | 84,000 | 4,130,340 (9%) | 0% | 47.4 | 3,984,960 | Common stock, par value $0.01 per share |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 74,515 | 0 | - | - | Employee Stock Options (right to buy) | |
| Cassava Sciences Inc | Richard J. Barry | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 19 Nov 2025 | 73,385 | 788,060 (4%) | 0% | 2.8 | 201,809 | Common Stock |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 73,349 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rezolute Inc | Brian Kenneth Roberts | Chief Medical Officer | 19 Nov 2025 | 72,000 | 72,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 71,970 | 844,394 (1%) | 0% | 16.6 | 1,195,422 | Common Stock |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 71,970 | 916,364 (1%) | 0% | 16.6 | 1,195,422 | Common Stock |
| Mitek Systems Inc | David B. Lyle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.72 per share. | 19 Nov 2025 | 68,808 | 193,218 (0%) | 0% | 8.7 | 600,006 | Common Stock |
| Mitek Systems Inc | David B. Lyle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 68,808 | 212,419 | - | - | Performance Restricted Stock Units | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 67,299 | 0 (0%) | 0% | - | Common Stock | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 19 Nov 2025 | 66,504 | 215,192,048 (32%) | 0% | 1.3 | 87,120 | Common Stock |
| Huntington Bancshares | Stephen D. Steinour | Director, President, CEO & Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 64,000 | 1,588,763 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Grp Inc | Katherine Bach Kalin | Director | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 19 Nov 2025 | 63,400 | 104,400 (2%) | 1% | 1.6 | 100,806 | Common Stock |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 63,000 | 63,000 | - | - | Employee Stock Option (Right to Buy) | |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 62,674 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 61,631 | 0 (0%) | 0% | - | Common Stock | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 19 Nov 2025 | 61,614 | 6,220,498 | - | 0.6 | 40,000 | Common Stock, par value $.001 |
| Celularity Inc (Class A) | Diane L. Parks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 61,539 | 365,021 | - | 0 | Class A Common Stock | |
| Intercontinental Exchange | Jeffrey C. Sprecher | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.62 per share. | 19 Nov 2025 | 60,639 | 1,891,066 (0%) | 0% | 152.6 | 9,254,785 | Common Stock |
| EZCorp Inc (Class A) | Nicole Swies | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 60,007 | 161,820 (0%) | 0% | 17.8 | 1,069,325 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Nicole Swies | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 60,007 | 88,002 | - | - | Restricted Stock Units | |
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 59,298 | 59,298 | - | - | Performance Based Restricted Stock Unit | |
| Medical Properties Trust Inc | Michael G. Stewart | Director | Sale of securities on an exchange or to another person at price $ 5.02 per share. | 19 Nov 2025 | 59,000 | 157,100 (0%) | 0% | 5.0 | 296,180 | Common stock, par value $0.001 |
| Elme Communities | Paul T. McDermott | Director, President, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 58,427 | 785,967 (0%) | 0% | 16.6 | 970,472 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 19 Nov 2025 | 58,160 | 215,060,933 (32%) | 0% | 1.3 | 74,736 | Common Stock |
| EZCorp Inc (Class A) | Lisa VanRoekel | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 57,855 | 142,918 (0%) | 0% | 17.8 | 1,030,976 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Lisa VanRoekel | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 57,855 | 114,979 | - | - | Restricted Stock Units | |
| Mitek Systems Inc | Garrett Gafke | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 8.72 per share. | 19 Nov 2025 | 57,340 | 177,532 (0%) | 0% | 8.7 | 500,005 | Common Stock |
| EZCorp Inc (Class A) | John Blair Powell | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 57,266 | 234,239 (0%) | 0% | 17.8 | 1,020,480 | Class A Non-Voting Common Stock |
| Theravance Biopharma Inc | Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.90 per share. | 19 Nov 2025 | 56,817 | 1,651,069 (2%) | 0% | 17.9 | 1,017,024 | Ordinary Shares |
| EZCorp Inc (Class A) | Lachlan P. Given | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 56,273 | 1,072,327 (2%) | 0% | 17.8 | 1,002,785 | Class A Non-Voting Common Stock |
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.29 per share. | 19 Nov 2025 | 56,193 | 5,131,842 (15%) | 0% | 7.3 | 409,647 | Common Stock |
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 56,193 | 0 | - | - | Stock Option Grant | |
| Ultralife Corp | Bradford T. Whitmore | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.97 per share. | 19 Nov 2025 | 53,900 | 1,182,631 (7%) | 0% | 5.0 | 267,915 | Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 53,622 | 188,889 (0%) | 0% | 17.8 | 955,544 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 53,622 | 122,409 | - | - | Restricted Stock Units | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 52,197 | 145,574 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 52,197 | 93,377 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 51,478 | 0 (0%) | 0% | - | Common Stock | |
| Airship AI Holdings Inc (Class A) | Victor Huang | Director, CEO and Chairman of the BOD, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.18 per share. | 19 Nov 2025 | 51,000 | 194,849 | - | 3.2 | 161,986 | Common Stock |
| Invivyd Inc | Kevin F. Mclaughlin | Director | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 19 Nov 2025 | 50,000 | 50,000 | - | 2.5 | 125,000 | Common Stock |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 19 Nov 2025 | 50,000 | 886,139 (2%) | 0% | 6.2 | 309,305 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 19 Nov 2025 | 50,000 | 886,139 (2%) | 0% | 6.2 | 309,305 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | 19 Nov 2025 | 50,000 | 25,299,280 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | 19 Nov 2025 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| EZCorp Inc (Class A) | Sunil Sajnani | Chief Audit/LP Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.82 per share. | 19 Nov 2025 | 49,388 | 115,630 (0%) | 0% | 17.8 | 880,094 | Class A Non-Voting Common Stock |
| EZCorp Inc (Class A) | Sunil Sajnani | Chief Audit/LP Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 49,388 | 81,754 | - | - | Restricted Stock Units | |
| Visa | Rajat Taneja | PRESIDENT, TECHNOLOGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 49,194 | 49,194 | - | - | Employee Stock Option (Right to Buy) | |
| Mitek Systems Inc | Jason L. Gray | GC, Secretary & Admin Officer | Grant, award, or other acquisition of securities at price $ 8.72 per share. | 19 Nov 2025 | 48,739 | 217,865 (0%) | 0% | 8.7 | 425,004 | Common Stock |
| Mitek Systems Inc | Jason L. Gray | GC, Secretary & Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 48,739 | 187,584 | - | - | Performance Restricted Stock Units | |
| Aeva Tech Inc | Saurabh Sinha | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.97 per share. | 19 Nov 2025 | 48,086 | 720,512 | - | 10.0 | 479,187 | Common Stock |
| Owens & Minor Inc | Andrew G. Long | EVP, CEO P&HS | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 47,908 | 214,064 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma PLC (Class A) | George Lloyd | EVP, Investments & CLO | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 19 Nov 2025 | 47,798 | 10,712 | - | 38.3 | 1,829,650 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | George Lloyd | EVP, Investments & CLO | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 19 Nov 2025 | 47,401 | 4,599 | - | 38.3 | 1,814,449 | Class A Ordinary Shares |
| Celularity Inc (Class A) | Peter H. Diamandis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 47,042 | 248,765 | - | 0 | Class A Common Stock | |
| EZCorp Inc (Class A) | John Blair Powell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 46,648 | 516,907 | - | - | Restricted Stock Units | |
| Intercontinental Exchange | Jeffrey C. Sprecher | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 46,000 | 1,116,991 (0%) | 0% | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Christopher Nathan Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 45,150 | 45,150 | - | - | Stock Options (Right to buy) | |
| Surmodics Inc | Gary R. Maharaj | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 45,073 | 0 | - | - | Employee Stock Option (right to buy) | |
| H&R Block Inc | Jeffrey J. Jones | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 45,000 | 990,130 (0%) | 0% | 0 | Common Stock | |
| Celularity Inc (Class A) | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 44,379 | 111,795 | - | 0 | Class A Common Stock | |
| Ashland Inc | Guillermo Novo | Director, Chair of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 43,495 | 43,495 | - | - | Restricted Stock Units | |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.28 per share. | 19 Nov 2025 | 42,999 | 929,138 (3%) | 0% | 6.3 | 270,004 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.28 per share. | 19 Nov 2025 | 42,999 | 929,138 (3%) | 0% | 6.3 | 270,004 | Common Stock |
| Proficient Auto Logistics Inc | John Skiadas | Director | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 19 Nov 2025 | 41,100 | 1,870,867 | - | 7.3 | 301,473 | Common Stock |
| Surmodics Inc | David R. Dantzker | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 40,183 | 0 (0%) | 0% | - | Common Stock | |
| Open Lending Corp | Matthew Sather | Chief Underwriting Officer | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 19 Nov 2025 | 40,000 | 44,363 | - | 1.5 | 60,800 | Common Stock, par value $0.01 per share |
| Cisco | Thimaya K. Subaiya | EVP, Operations | Sale of securities on an exchange or to another person at price $ 78.50 per share. | 19 Nov 2025 | 39,976 | 179,779 (0%) | 0% | 78.5 | 3,137,992 | Common Stock |
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 39,532 | 207,238 (0%) | 0% | 0 | Common Shares | |
| Surmodics Inc | Susan E. Knight | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 37,240 | 0 (0%) | 0% | - | Common Stock | |
| Soluna Holdings Inc | William P. Phelan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 36,500 | 134,971 | - | 0 | 9.0% Series A Cumulative Perpetual Preferred Stock | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 19 Nov 2025 | 36,325 | 215,002,773 (32%) | 0% | 1.3 | 46,496 | Common Stock |
| Visa | Christopher Suh | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 36,076 | 36,076 | - | - | Employee Stock Option (Right to Buy) | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 35,984 | 181,558 (0%) | 0% | 0 | Common Stock | |
| EZCorp Inc (Class A) | Timothy K. Jugmans | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 35,201 | 202,835 (0%) | 0% | 17.8 | 627,282 | Class A Non-Voting Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 19 Nov 2025 | 35,000 | 3,271,453 | - | 0.5 | 17,329 | Common Stock |
| Nelnet Inc (Class A) | Michael S. Dunlap | Director, Executive Chairman of Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 35,000 | 1,382,982 (4%) | 0% | 0 | Class A Common Stock | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 34,703 | 0 (0%) | 0% | - | Common Stock | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 34,105 | 115,435 (0%) | 0% | 16.6 | 566,484 | Common Stock |
| Sensata Tech Holding PLC | John Mirshekari | Director | Sale of securities on an exchange or to another person at price $ 29.53 per share. | 19 Nov 2025 | 33,933 | 0 (0%) | 0% | 29.5 | 1,002,041 | Ordinary Shares, par value EUR 0.01 per share |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO AND CHAIR | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 19 Nov 2025 | 33,838 | 1,238,230 | - | 2.0 | 66,708 | Class A Common Stock |
| Keysight Tech | Satish Dhanasekaran | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 33,266 | 148,939 (0%) | 0% | 0 | Common Stock | |
| Cabot Corp | Sean D. Keohane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 32,630 | 383,540 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 32,018 | 149,540 (0%) | 0% | 16.6 | 531,819 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Sale of securities on an exchange or to another person at price $ 72.13 per share. | 19 Nov 2025 | 32,000 | 46,086 (0%) | 0% | 72.1 | 2,308,240 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 19 Nov 2025 | 32,000 | 78,086 (0%) | 0% | 63.9 | 2,044,800 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 32,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Rezolute Inc | Sunil Karnawat | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 32,000 | 59,442 | - | 0 | Common Shares | |
| Cabot Corp | Erica J. McLaughlin | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 30,998 | 30,998 | - | - | Employee Stock Option (Right to Buy) | |
| Cabot Corp | Sean D. Keohane | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 30,932 | 414,472 (0%) | 0% | 0 | Common Stock | |
| Snap Inc (Class A) | Rebecca Morrow | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 30,451 | 497,054 (0%) | 0% | 0 | Class A Common Stock | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 19 Nov 2025 | 30,082 | 215,112,551 (32%) | 0% | 1.3 | 39,107 | Common Stock |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 30,008 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 29,582 | 0 | - | - | Employee Stock Option (right to buy) | |
| EZCorp Inc (Class A) | Timothy K. Jugmans | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 29,482 | 348,968 | - | - | Restricted Stock Units | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 28,864 | 0 | - | - | Employee Stock Option (right to buy) | |
| Carlyle Grp Inc | Harvey M. Schwartz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 28,519 | 6,240,292 (1%) | 0% | 0 | Common Stock | |
| Visa | Kelly Mahon Tullier | VICE CHAIR, CHF PPL & CORP AFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 27,877 | 27,877 | - | - | Employee Stock Option (Right to Buy) | |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 27,784 | 70,420 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 27,784 | 98,204 (0%) | 0% | 0 | Common Stock | |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 26,953 | 26,953 | - | - | Performance Based Restricted Stock Unit | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 26,548 | 0 | - | - | Employee Stock Option (right to buy) | |
| Radnet Inc | Howard G. Berger | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 25,992 | 51,984 | - | - | Stock Option (right to buy) | |
| Radnet Inc | Howard G. Berger | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.64 per share. | 19 Nov 2025 | 25,992 | 348,412 (0%) | 0% | 18.6 | 484,491 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 25,696 | 5,731,801 | - | 0 | Common Stock | |
| Royalty Pharma PLC (Class A) | George Lloyd | EVP, Investments & CLO | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 19 Nov 2025 | 25,530 | 2,470 | - | 38.3 | 977,260 | Class A Ordinary Shares |
| Stride Inc | James J. Rhyu | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 25,177 | 752,009 (1%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 25,016 | 0 | - | - | Employee Stock Option (right to buy) | |
| Kayne Anderson Energy infra Fund Inc | James C. Baker | Director, President | Purchase of securities on an exchange or from another person at price $ 11.81 per share. | 19 Nov 2025 | 25,000 | 861,040 (0%) | 0% | 11.8 | 295,250 | Common Stock |
| Visa | Paul D. Fabara | CHIEF RISK & CLIENT SVCS OFC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 24,597 | 24,597 | - | - | Employee Stock Option (Right to Buy) | |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 24,597 | 24,597 | - | - | Employee Stock Option (Right to Buy) | |
| Medtronic | Gregory L. Smith | EVP Global Ops & Supply Chain | Sale of securities on an exchange or to another person at price $ 101.93 per share. | 19 Nov 2025 | 24,186 | 51,830 (0%) | 0% | 101.9 | 2,465,279 | Ordinary Shares |
| QuidelOrtho Corporation | Brian J. Blaser | President and CEO | Purchase of securities on an exchange or from another person at price $ 21.34 per share. | 19 Nov 2025 | 23,500 | 29,533 (0%) | 0% | 21.3 | 501,577 | Common Stock |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 23,292 | 121,496 (0%) | 0% | 0 | Common Stock | |
| Ashland Inc | William C. Whitaker | SVP, CFO & PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 23,131 | 23,131 | - | - | Stock Appreciation Rights | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.55 per share. | 19 Nov 2025 | 22,992 | 15,912 | - | 74.6 | 1,714,139 | Class A Common Stock |
| EZCorp Inc (Class A) | Lisa VanRoekel | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 22,768 | 120,150 (0%) | 0% | 17.8 | 405,726 | Class A Non-Voting Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 22,754 | 22,754 | - | - | Restricted Stock Units | |
| Cabot Corp | Jeff Ji Zhu | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 22,544 | 22,544 | - | - | Employee Stock Option (Right to Buy) | |
| Brady Corp (Class A) | Elizabeth P. Bruno | Director | Sale of securities on an exchange or to another person at price $ 74.69 per share. | 19 Nov 2025 | 22,462 | 575,000 (1%) | 0% | 74.7 | 1,677,687 | Class A Common Stock (Elizabeth Bruno GST Non-Exempt Trust) |
| EZCorp Inc (Class A) | Nicole Swies | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 22,416 | 139,404 (0%) | 0% | 17.8 | 399,453 | Class A Non-Voting Common Stock |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.74 per share. | 19 Nov 2025 | 22,396 | 332,498 (0%) | 0% | 34.7 | 778,037 | COMMON STOCK |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 21,255 | 335,564 (0%) | 0% | 0 | COMMON STOCK | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 21,255 | 42,505 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 19 Nov 2025 | 21,236 | 215,082,469 (32%) | 0% | 1.3 | 27,501 | Common Stock |
| Orion Energy Systems Inc | Sally Washlow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.17 per share. | 19 Nov 2025 | 21,166 | 46,524 (0%) | 0% | 14.2 | 299,922 | Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 21,103 | 167,786 (0%) | 0% | 17.8 | 376,055 | Class A Non-Voting Common Stock |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 21,040 | 0 (0%) | 0% | - | Common Stock | |
| Rezolute Inc | Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 55,500 | - | 0 | Common Shares | |
| Rezolute Inc | Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 55,500 | - | 0 | Common Shares | |
| Rezolute Inc | Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 58,576 | - | 0 | Common Shares | |
| Rezolute Inc | Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 114,025 | - | 0 | Common Shares | |
| Rezolute Inc | Erik Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 21,000 | - | 0 | Common Shares | |
| Rezolute Inc | Young-jin Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 21,000 | 170,950 | - | 0 | Common Shares | |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 20,859 | 0 | - | - | Employee Stock Option (right to buy) | |
| Procore Tech Inc | Craig F. Courtemanche | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.74 per share. | 19 Nov 2025 | 20,673 | 657,123 | - | 71.7 | 1,483,081 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.57 per share. | 19 Nov 2025 | 20,441 | 5,725,911 | - | 40.6 | 829,291 | Common Stock |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 20,101 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 20,101 | 0 | - | - | Employee Stock Option (right to buy) | |
| Accuray Inc | Stephen R. LaNeve | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 19 Nov 2025 | 20,000 | 20,000 (0%) | 0% | 1.0 | 19,410 | Common Stock |
| Eastside Distilling Inc | Christopher Redmond Moe | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 19 Nov 2025 | 20,000 | 40,000 (0%) | 0% | 1.7 | 33,600 | Common Stock |
| FirstCash Holdings Inc | Rick L. Wessel | Director, Vice-Chairman & CEO | Sale of securities on an exchange or to another person at price $ 156.39 per share. | 19 Nov 2025 | 20,000 | 866,982 (2%) | 0% | 156.4 | 3,127,800 | Common Stock |
| TTM Tech Inc | Julie S. England | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.83 per share. | 19 Nov 2025 | 20,000 | 110,325 (0%) | 0% | 11.8 | 236,600 | Common Stock |
| TTM Tech Inc | Julie S. England | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 20,000 | 106,541 | - | - | Director Stock Option Right to Buy | |
| Addus HomeCare Corp | Darby Anderson | EVP, Chief Govt Rel Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 20,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Addus HomeCare Corp | Darby Anderson | EVP, Chief Govt Rel Officer | Sale of securities on an exchange or to another person at price $ 109.00 per share. | 19 Nov 2025 | 20,000 | 44,144 (0%) | 0% | 109 | 2,180,000 | Common Stock |
| Addus HomeCare Corp | Darby Anderson | EVP, Chief Govt Rel Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.70 per share. | 19 Nov 2025 | 20,000 | 64,144 (0%) | 0% | 22.7 | 454,000 | Common Stock |
| WW Intl Inc - Ordinary Shares - New | J. Carney Hawks | Director | Purchase of securities on an exchange or from another person at price $ 22.75 per share. | 19 Nov 2025 | 20,000 | 20,000 (0%) | 0% | 22.8 | 455,000 | Common Stock |
| NMI Holdings Inc (Class A) | Michael J. Embler | Director | Sale of securities on an exchange or to another person at price $ 36.90 per share. | 19 Nov 2025 | 20,000 | 46,046 (0%) | 0% | 36.9 | 738,000 | Common Shares, $0.01 par value per share |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,912 | 74,022 (0%) | 0% | 0 | Common Stock | |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,912 | 93,934 (0%) | 0% | 0 | Common Stock | |
| Tetra Tech Inc | Leslie L. Shoemaker | EVP, Chief Sustainability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,641 | 19,641 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Tetra Tech Inc | Steven M. Burdick | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,641 | 19,641 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Tetra Tech Inc | Roger R. Argus | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,641 | 19,641 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 19,330 | 57,990 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Tetra Tech Inc | Dan L. Batrack | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 19,330 | 354,894 (0%) | 0% | 0 | COMMON STOCK | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 19,243 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 19,243 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 19,243 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cohen & Steers Inc | Robert H. Steers | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 59.88 per share. | 19 Nov 2025 | 19,000 | 7,147,497 (14%) | 0% | 59.9 | 1,137,720 | Common Stock |
| Rezolute Inc | Sunil Karnawat | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 19,000 | 19,000 | - | - | Employee Stock Option (Right to Buy) | |
| Elme Communities | Tiffany Michelle Butcher | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 18,557 | 96,878 (0%) | 0% | 16.6 | 308,232 | Common Stock |
| Intapp Inc | David H. Morton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 18,370 | 55,225 | - | 0 | Common Stock | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 18,039 | 86,454 (0%) | 0% | 16.6 | 299,628 | Common Stock |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 17,969 | 118,570 (0%) | 0% | 0 | Common Shares | |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Sale of securities on an exchange or to another person at price $ 205.47 per share. | 19 Nov 2025 | 17,920 | 85,101 (0%) | 0% | 205.5 | 3,682,022 | Common Stock |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Sale of securities on an exchange or to another person at price $ 206.51 per share. | 19 Nov 2025 | 17,891 | 67,210 (0%) | 0% | 206.5 | 3,694,670 | Common Stock |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Option (right to buy) | |
| RYTHM Inc | Benjamin Kovler | Director, Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.19 per share. | 19 Nov 2025 | 17,526 | 65,849 | - | 19.2 | 336,324 | Common Stock |
| Intapp Inc | David H. Morton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.57 per share. | 19 Nov 2025 | 17,455 | 53,765 | - | 40.6 | 708,149 | Common Stock |
| Payoneer Global Inc | Tsafi Goldman | Chief Legal & Governance Ofcr. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.54 per share. | 19 Nov 2025 | 17,282 | 704,836 | - | 5.5 | 95,742 | Common Stock |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 17,003 | 104,493 (0%) | 0% | 16.6 | 282,420 | Common Stock |
| Cabot Corp | Karen A. Kalita | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 16,908 | 16,908 | - | - | Employee Stock Option (Right to Buy) | |
| EZCorp Inc (Class A) | Lisa VanRoekel | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 16,317 | 172,834 | - | - | Restricted Stock Units | |
| Cisco | Thimaya K. Subaiya | EVP, Operations | Sale of securities on an exchange or to another person at price $ 77.90 per share. | 19 Nov 2025 | 16,062 | 219,755 (0%) | 0% | 77.9 | 1,251,272 | Common Stock |
| EZCorp Inc (Class A) | Ellen .H Bryant | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 16,020 | 176,031 | - | - | Restricted Stock Units | |
| PTC | Kristian P. Talvitie | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 15,993 | 15,993 | - | - | Restricted Stock Units | |
| Keysight Tech | Satish Dhanasekaran | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 15,776 | 123,495 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 15,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 15,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 15,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 15,414 | 109,348 (0%) | 0% | 0 | Common Stock | |
| EZCorp Inc (Class A) | Nicole Swies | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 15,310 | 148,009 | - | - | Restricted Stock Units | |
| Keysight Tech | Neil Dougherty | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 15,207 | 130,740 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Adam S. Grossman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 19 Nov 2025 | 15,000 | 2,034,850 (2%) | 0% | 5.4 | 81,000 | Common Stock |
| Adma Biologics Inc | Adam S. Grossman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 15,000 | 735,950 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Adam S. Grossman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 19 Nov 2025 | 15,000 | 2,019,850 (2%) | 0% | 16 | 240,000 | Common Stock |
| Fulcrum Therapeutics Inc | Robert J. Gould | Director | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 19 Nov 2025 | 15,000 | 484,864 (2%) | 0% | 11.0 | 165,495 | Common Stock |
| Robinhood Markets Inc (Class A) | Jason Warnick | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 15,000 | 448,691 | - | 0 | Class A Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.55 per share. | 19 Nov 2025 | 14,923 | 5,968,929 | - | 74.6 | 1,112,565 | Class A Common Stock |
| Ashland Inc | Osama M. Musa | SVP and CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 14,354 | 14,354 | - | - | Stock Appreciation Rights | |
| Rayonier Inc | Christopher T. Corr | SVP, Real Estate Development | Sale of securities on an exchange or to another person at price $ 21.12 per share. | 19 Nov 2025 | 14,255 | 57,290 (0%) | 0% | 21.1 | 301,066 | Common Shares |
| Tetra Tech Inc | Preston Hopson | EVP, Chief Legal/Human Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 14,029 | 14,029 | - | - | RESTRICTED STOCK UNITS (RIGHT TO RECEIVE) | |
| Cathay General Bancorp | Dunson K. Cheng | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 46.24 per share. | 19 Nov 2025 | 14,000 | 155,950 (0%) | 0% | 46.2 | 647,415 | Common Stock |
| Surmodics Inc | Lisa Wipperman Heine | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 13,978 | 0 (0%) | 0% | - | Common Stock | |
| Ashland Inc | Alessandra Faccin Assis | SVP and GM, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 13,807 | 13,807 | - | - | Stock Appreciation Rights | |
| Valvoline Inc | Lori Ann Flees | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 13,690 | 64,920 (0%) | 0% | - | Common Stock | |
| J&J Snack Foods Corp | Daniel J. Fachner | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 13,626 | 49,336 (0%) | 0% | 0 | Common stock, no par value | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 13,579 | 0 | - | - | Employee Stock Option (right to buy) | |
| EZCorp Inc (Class A) | Sunil Sajnani | Chief Audit/LP Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 13,153 | 131,142 | - | - | Restricted Stock Units | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 19 Nov 2025 | 12,993 | 215,125,544 (32%) | 0% | 1.3 | 16,956 | Common Stock |
| Construction Partners Inc (Class A) | Fred J. Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.02 per share. | 19 Nov 2025 | 12,785 | 47,211 (0%) | 0% | 112.0 | 1,432,176 | Class A Common Stock |
| Lifevantage Corp | Michael A. Beindorff | Director | Sale of securities on an exchange or to another person at price $ 6.42 per share. | 19 Nov 2025 | 12,607 | 43,806 (0%) | 0% | 6.4 | 80,934 | Common Stock |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 12,595 | 76,704 (0%) | 0% | 16.6 | 209,203 | Common Stock |
| Surmodics Inc | Joseph J. Stich | SVP of HR, President IVD | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 12,292 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 12,292 | 0 | - | - | Employee Stock Option (right to buy) | |
| PTC | Aaron C. Von Staats | EVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,213 | 12,213 | - | - | Restricted Stock Units | |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 12,183 | 97,165 (0%) | 0% | 16.6 | 202,360 | Common Stock |
| MEI Pharma Inc | James Flynn | Director | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 19 Nov 2025 | 12,100 | 30,000 (0%) | 0% | 1.9 | 22,777 | Common Stock |
| EZCorp Inc (Class A) | Sunil Sajnani | Chief Audit/LP Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.82 per share. | 19 Nov 2025 | 12,028 | 103,602 (0%) | 0% | 17.8 | 214,339 | Class A Non-Voting Common Stock |
| Enliven Therapeutics Inc | Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 22.30 per share. | 19 Nov 2025 | 12,008 | 903,180 | - | 22.3 | 267,794 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.05 per share. | 19 Nov 2025 | 12,000 | 58,086 (0%) | 0% | 40.1 | 480,600 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Sale of securities on an exchange or to another person at price $ 72.13 per share. | 19 Nov 2025 | 12,000 | 46,086 (0%) | 0% | 72.1 | 865,590 | Common Stock |
| Ionis Pharma Inc | Joan E. Herman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Rezolute Inc | Gil M. Labrucherie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Rezolute Inc | Philippe Fauchet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Rezolute Inc | Nerissa C. Kreher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Rezolute Inc | Wladimir Hogenhuis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Rezolute Inc | Erik Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Rezolute Inc | Young-jin Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 12,000 | - | - | Director Stock Option (Right to Buy) | |
| Zeta Global Holdings Corp (Class A) | William Landman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 12,000 | 260,951 | - | 0 | Class A Common Stock | |
| Elme Communities | Steven M. Freishtat | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 11,896 | 74,558 (0%) | 0% | 16.6 | 197,593 | Common Stock |
| Starbucks | Brian R. Niccol | Director, chairman and ceo | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.69 per share. | 19 Nov 2025 | 11,821 | 474,470 (0%) | 0% | 83.7 | 989,253 | Common Stock |
| Visa | Rajat Taneja | PRESIDENT, TECHNOLOGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 11,570 | 11,570 | - | - | Restricted Stock Units | |
| Surmodics Inc | Gordon S. Weber | Sr. VP of Legal, GC and Sec. | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 11,538 | 0 | - | - | Employee Stock Options (right to buy) | |
| Epsilon Energy Ltd | Jason Stabell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.82 per share. | 19 Nov 2025 | 11,500 | 496,839 (1%) | 0% | 4.8 | 55,453 | Common Shares |
| Keysight Tech | Kailash Narayanan | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 11,405 | 48,084 (0%) | 0% | 0 | Common Stock | |
| Ashland Inc | James P. Minicucci | SVP and GM, Personal Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 11,361 | 11,361 | - | - | Stock Appreciation Rights | |
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.41 per share. | 19 Nov 2025 | 11,258 | 5,075,649 (14%) | 0% | 10.4 | 117,196 | Common Stock |
| Liquidity Services Inc | William P. Angrick | Director, Chairman of the Board and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 11,258 | 120,692 | - | - | Stock Option Grant | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.48 per share. | 19 Nov 2025 | 11,121 | 4,791 | - | 75.5 | 839,404 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 73.58 per share. | 19 Nov 2025 | 11,096 | 38,904 | - | 73.6 | 816,461 | Class A Common Stock |
| Strata Critical Medical Inc (Class A) | Reginald L. Love | Director | Sale of securities on an exchange or to another person at price $ 4.31 per share. | 19 Nov 2025 | 11,000 | 124,897 | - | 4.3 | 47,434 | Class A common stock, $0.0001 par value per share |
| Courtside Grp Inc | D. Jonathan Merriman | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 19 Nov 2025 | 11,000 | 264,079 | - | 2.2 | 24,200 | Common Stock, $0.00001 par value |
| Celsius Holdings Inc | Tony Guilfoyle | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.20 per share. | 19 Nov 2025 | 10,832 | 80,202 (0%) | 0% | 41.2 | 446,278 | Common Stock, $0.001 par value per share |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 10,653 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 10,653 | 0 | - | - | Employee Stock Option (right to buy) | |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.09 per share. | 19 Nov 2025 | 10,552 | 94,380 (0%) | 0% | 50.1 | 528,550 | Common Stock |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 10,552 | 0 | - | - | Employee stock option to purchase common stock | |
| Cabot Corp | Sean D. Keohane | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.76 per share. | 19 Nov 2025 | 10,338 | 404,134 (0%) | 0% | 59.8 | 617,799 | Common Stock |
| Ashland Inc | William C. Whitaker | SVP, CFO & PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 10,280 | 10,280 | - | - | Restricted Stock Units | |
| AMD | Forrest E. Norrod | EVP & GM DESG | Sale of securities on an exchange or to another person at price $ 229.21 per share. | 19 Nov 2025 | 10,188 | 306,310 (0%) | 0% | 229.2 | 2,335,191 | Common Stock |
| UroGen Pharma Ltd | Mark P. Schoenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 19 Nov 2025 | 10,000 | 139,025 (0%) | 0% | 25 | 250,000 | Ordinary Shares |
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 19 Nov 2025 | 10,000 | 10,072 | - | 38.1 | 380,800 | Class A Common Stock | |
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 10,000 | 5,252 | - | - | Stock Option (Right to Buy) | |
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 19 Nov 2025 | 10,000 | 124,305 | - | - | Class B Common Stock | ||
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 19 Nov 2025 | 10,000 | 114,305 | - | - | Class B Common Stock | ||
| Natural Gas Services Grp Inc | Stephen C. Taylor | Director | Sale of securities on an exchange or to another person at price $ 31.37 per share. | 19 Nov 2025 | 10,000 | 315,432 (2%) | 0% | 31.4 | 313,700 | Common Stock |
| Natural Gas Services Grp Inc | Stephen C. Taylor | Director | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 19 Nov 2025 | 10,000 | 325,432 (2%) | 0% | 30.3 | 303,100 | Common Stock |
| Pebblebrook Hotel Trust | Michael J. Schall | Director | Purchase of securities on an exchange or from another person at price $ 10.85 per share. | 19 Nov 2025 | 10,000 | 119,693 (0%) | 0% | 10.9 | 108,500 | Common Shares |
| Cathay General Bancorp | Dunson K. Cheng | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 47.85 per share. | 19 Nov 2025 | 10,000 | 145,950 (0%) | 0% | 47.9 | 478,524 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 10,000 | 339,768 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 29.10 per share. | 19 Nov 2025 | 10,000 | 349,768 (1%) | 0% | 29.1 | 290,983 | Common Stock |
| Netscout Systems Inc | Joseph G. Hadzima | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 10,000 | 118,185 (0%) | 0% | 0 | Common Stock | |
| Theravance Biopharma Inc | Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 9,900 | 1,707,886 (2%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 9,900 | 23,400 (0%) | 0% | 0 | Ordinary Shares | |
| Epsilon Energy Ltd | Jason Stabell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.77 per share. | 19 Nov 2025 | 9,700 | 506,539 (1%) | 0% | 4.8 | 46,269 | Common Shares |
| Ashland Inc | Dago Caceres | SVP & GM, Specialty Additives | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 9,564 | 9,564 | - | - | Stock Appreciation Rights | |
| Intapp Inc | Thad Jampol | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 9,562 | 888,996 | - | 0 | Common Stock | |
| Arch Capital | David E. Gansberg | President, Arch Capital Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.17 per share. | 19 Nov 2025 | 9,494 | 309,888 (0%) | 0% | 91.2 | 865,568 | Common Shares, $.0011 par value per share |
| Intapp Inc | Don Coleman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 9,389 | 451,450 | - | 0 | Common Stock | |
| Keysight Tech | Ingrid A. Estrada | SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 9,266 | 115,865 (0%) | 0% | 0 | Common Stock | |
| AES | Ricardo Manuel Falu | EVP, COO, Pres. New Enrgy Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.77 per share. | 19 Nov 2025 | 9,240 | 108,191 (0%) | 0% | 13.8 | 127,235 | Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 324.12 per share. | 19 Nov 2025 | 9,147 | 9,401 (0%) | 0% | 324.1 | 2,964,726 | Class A Common Stock |
| Sky Harbour Grp Corp (Class A) | Francisco X. Gonzalez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.57 per share. | 19 Nov 2025 | 9,100 | 515,718 | - | 8.6 | 77,987 | Class A Common Stock |
| WW Intl Inc - Ordinary Shares - New | J. Carney Hawks | Director | Purchase of securities on an exchange or from another person at price $ 20.81 per share. | 19 Nov 2025 | 9,057 | 29,057 (0%) | 0% | 20.8 | 188,464 | Common Stock |
| Proficient Auto Logistics Inc | John Skiadas | Director | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 19 Nov 2025 | 9,010 | 1,918,587 | - | 7.2 | 65,170 | Common Stock |
| Bakkt Holdings Inc (Class A) | Michael Alfred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 9,000 | 28,476 | - | 0 | Class A Common Stock | |
| Intapp Inc | David Benjamin Harrison | President, Industries | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,929 | 8,929 | - | 0 | Common Stock | |
| Ashland Inc | Robin E. Lampkin | SVP, Gen Counsel and Secrty. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,922 | 8,922 | - | - | Stock Appreciation Rights | |
| Ashland Inc | Eileen Drury | SVP and Chief HRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,897 | 8,897 | - | - | Stock Appreciation Rights | |
| NCR Atleos Corp | Michelle McKinney Frymire | Director | Sale of securities on an exchange or to another person at price $ 35.02 per share. | 19 Nov 2025 | 8,786 | 10,838 | - | 35.0 | 307,686 | Common Stock |
| Intapp Inc | David H. Morton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,699 | 71,220 | - | 0 | Common Stock | |
| Intapp Inc | David H. Morton | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,699 | 69,589 | - | - | Restricted Share Units | |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,641 | 0 | - | - | Employee stock option to purchase common stock | |
| SPX Tech Inc | John William Swann | PRES., DETECTION & MEASUREMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.97 per share. | 19 Nov 2025 | 8,641 | 103,021 (0%) | 0% | 49.0 | 423,150 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,604 | 60,276 | - | - | Restricted Share Units | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,604 | 5,740,405 | - | 0 | Common Stock | |
| Visa | Christopher Suh | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,485 | 8,485 | - | - | Restricted Stock Units | |
| Charles Schwab | Charles A. Ruffel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 8,372 | 9,778 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Teri Woodwick Sides | SVP, Vascular Interventions | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 8,356 | 0 | - | - | Employee Stock Option (right to buy) | |
| Silvaco Grp Inc | Candace Jackson | See Remarks | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 19 Nov 2025 | 8,300 | 43,069 | - | 4.3 | 35,275 | Common Stock |
| Cabot Corp | Erica J. McLaughlin | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,283 | 73,098 (0%) | 0% | 0 | Common Stock | |
| Lear Corp | Raymond E. Scott | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,275 | 8,275 | - | - | Restricted Stock Units | |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 294.17 per share. | 19 Nov 2025 | 8,237 | 2,324,057 (0%) | 0% | 294.2 | 2,423,078 | Class C Capital Stock |
| Duke Energy | Robert Alexander Glenn | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 123.80 per share. | 19 Nov 2025 | 8,200 | 11,367 (0%) | 0% | 123.8 | 1,015,160 | Common Stock |
| AMD | Forrest E. Norrod | EVP & GM DESG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.19 per share. | 19 Nov 2025 | 8,200 | 319,798 (0%) | 0% | 34.2 | 280,358 | Common Stock |
| AMD | Forrest E. Norrod | EVP & GM DESG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 8,200 | 16,437 | - | - | Stock Option Grant | |
| Advanced Energy Ind Inc | Paul R. Oldham | EVP, CFO | Sale of securities on an exchange or to another person at price $ 203.11 per share. | 19 Nov 2025 | 8,174 | 24,792 (0%) | 0% | 203.1 | 1,660,221 | Common Stock |
| Surmodics Inc | John D. Manders | VP Finance, Corp. Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 8,155 | 0 (0%) | 0% | - | Common Stock | |
| Keysight Tech | Neil Dougherty | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 8,051 | 119,525 (0%) | 0% | 0 | Common Stock | |
| General Electric Co. | Russell Stokes | Senior Vice President | Sale of securities on an exchange or to another person at price $ 297.71 per share. | 19 Nov 2025 | 8,000 | 150,434 (0%) | 0% | 297.7 | 2,381,680 | Common Stock |
| Sarcos Tech and Robotics Corp | Benjamin G. Wolff | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 19 Nov 2025 | 8,000 | 2,833,401 | - | 5.4 | 43,232 | Common Stock |
| PTC | Kristian P. Talvitie | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 7,996 | 7,996 | - | - | Restricted Stock Units | |
| PTC | Kristian P. Talvitie | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 7,996 | 7,996 | - | - | Restricted Stock Units | |
| Elme Communities | W. Drew Hammond | SVP, CAO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 19 Nov 2025 | 7,866 | 89,299 (0%) | 0% | 16.6 | 130,654 | Common Stock |
| Keysight Tech | Jeffrey K. Li | SVP and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 7,841 | 41,566 (0%) | 0% | 0 | Common Stock | |
| Keysight Tech | Satish Dhanasekaran | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.61 per share. | 19 Nov 2025 | 7,822 | 115,673 (0%) | 0% | 174.6 | 1,365,799 | Common Stock |
| Visa | Ryan McInerney | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 7,800 | 239,526 (0%) | 0% | 0 | Class A Common Stock | |
| Intapp Inc | Thad Jampol | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.57 per share. | 19 Nov 2025 | 7,515 | 886,712 | - | 40.6 | 304,884 | Common Stock |
| Accelerant Holdings (Class A) | Samuel Gaynor | Director | Purchase of securities on an exchange or from another person at price $ 13.44 per share. | 19 Nov 2025 | 7,500 | 7,500 | - | 13.4 | 100,774 | Class A Common Shares |
| Unum Grp | Steven Andrew Zabel | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.38 per share. | 19 Nov 2025 | 7,500 | 113,807 (0%) | 0% | 76.4 | 572,865 | Common Stock |
| Intapp Inc | Michele Murgel | Chief People & Places Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 7,421 | 200,806 | - | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | James Laufman | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.88 per share. | 19 Nov 2025 | 7,379 | 224,905 | - | 141.9 | 1,046,933 | Ordinary Shares |
| Intapp Inc | Don Coleman | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.57 per share. | 19 Nov 2025 | 7,327 | 449,154 | - | 40.6 | 297,256 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.48 per share. | 19 Nov 2025 | 7,220 | 5,961,709 | - | 75.5 | 544,960 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 73.58 per share. | 19 Nov 2025 | 7,203 | 5,983,852 | - | 73.6 | 530,008 | Class A Common Stock |
| AES | Juan Ignacio Rubiolo | EVP and Pres., Energy Infrast. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.77 per share. | 19 Nov 2025 | 7,121 | 188,445 (0%) | 0% | 13.8 | 98,056 | Common Stock |
| Natera Inc | Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share. | 19 Nov 2025 | 7,068 | 26,027 (0%) | 0% | 41.2 | 291,131 | Common Stock |
| Natera Inc | Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 7,068 | 0 | - | - | Stock Option (right to buy) | |
| Eastside Distilling Inc | Joseph Freedman | Director | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 19 Nov 2025 | 7,000 | 360,891 (3%) | 0% | 1.6 | 11,340 | Common Stock |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2025 | 7,000 | 371,005 (1%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.